efanesoctocog alfa (BIVV001)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for efanesoctocog alfa (BIVV001), covering 2025-08-01 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD) [Phase 1]